Free Trial

Viracta Therapeutics (VIRX) Insider Trading & Ownership

Viracta Therapeutics logo
$0.16 +0.01 (+6.64%)
(As of 11/22/2024 ET)

Viracta Therapeutics (NASDAQ:VIRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.69%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$25,526.06
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$4,345.65
Get VIRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Viracta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VIRX Insider Buying and Selling by Quarter

Viracta Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2024Daniel R ChevallardCFOSell3,405$0.73$2,485.65  
11/30/2023Mark RotheraCEOBuy52,094$0.49$25,526.06  
11/28/2023Daniel R ChevallardCFOSell3,720$0.50$1,860.00  
(Data available from 1/1/2013 forward)

VIRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Viracta Therapeutics includes Daniel R Chevallard, Ivor Royston, Lisa Rojkjaer, and Mark Rothera. Learn more on insiders at VIRX.

10.69% of Viracta Therapeutics stock is owned by insiders. Learn more on VIRX's insider holdings.

The following insider purchased VIRX shares in the last 24 months: Mark Rothera ($25,526.06).

Insiders have purchased a total of 52,094 VIRX shares in the last 24 months for a total of $25,526.06 bought.

The following insiders have sold VIRX shares in the last 24 months: Daniel R Chevallard ($30,253.11), and Lisa Rojkjaer ($9,377.60).

Insiders have sold a total of 25,675 Viracta Therapeutics shares in the last 24 months for a total of $39,630.71 sold.

Viracta Therapeutics Key Executives

  • Mr. Mark Andrew Rothera (Age 61)
    CEO, President & Director
    Compensation: $365.03k
  • Dr. Susan Perrine M.D.
    Scientific Founder and Consultant
  • Dr. Ronald J. Berenson M.D. (Age 72)
    Co-Founder and Consultant
  • Mr. George Hillman
    Co-Founder
  • Dr. Thalia Papayannopoulou M.D.
    Co-Founder
  • Dr. Robert M. Williams Ph.D. (Age 69)
    Co-Founder
  • Dr. Douglas V. Faller M.D.
    Ph.D., Scientific Founder & Chairman of Scientific Advisory Board
  • Ms. Melody Burcar CPA (Age 41)
    M.B.A., Senior VP of Finance, Interim Principal Financial Officer & Interim Principal Accounting Officer
  • Dr. Ayman El-Guindy
    Chief Scientific Officer
  • Mr. Stewart M. Brown
    Senior VP of Legal Affairs & General Counsel


This page (NASDAQ:VIRX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners